Merck cancer drug is first approved under UK early access scheme
March 11, 2015 at 03:38 AM EDT
LONDON, March 11 (Reuters) - Merck & Co's cancer drug Keytruda, which works by boosting the immune system but has yet to be licensed in Europe, is the first medicine to be made available to patients in Britain under a new early access scheme.
